137 related articles for article (PubMed ID: 18696327)
21. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
22. Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese.
Montine TJ; Underhill TM; Linney E; Graham DG
Toxicol Appl Pharmacol; 1994 Sep; 128(1):116-22. PubMed ID: 8079344
[TBL] [Abstract][Full Text] [Related]
23. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal regulation of the content of aromatic L-amino acid decarboxylase and tyrosine hydroxylase mRNA by NGF in PC12 cells.
Li XM; Qi J; Juorio AV; Boulton AA
J Neurosci Res; 1997 Feb; 47(4):449-54. PubMed ID: 9057138
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of L-dopa and aromatic L-amino acid-decarboxylase in the rat retina.
Nguyen-Legros J; Krieger M; Simon A
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2906-15. PubMed ID: 8206708
[TBL] [Abstract][Full Text] [Related]
26. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
Shimamura M; Shimizu M; Yagami T; Funabashi T; Kimura F; Kuroiwa Y; Misu Y; Goshima Y
Neuropharmacology; 2006 Jun; 50(8):909-16. PubMed ID: 16504219
[TBL] [Abstract][Full Text] [Related]
27. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of L-DOPA-induced cytotoxicity in rat adrenal pheochromocytoma cells: implication of oxidative stress-related kinases and cyclic AMP.
Jin CM; Yang YJ; Huang HS; Kai M; Lee MK
Neuroscience; 2010 Oct; 170(2):390-8. PubMed ID: 20670675
[TBL] [Abstract][Full Text] [Related]
29. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
Ugrumov MV
J Soc Biol; 2009; 203(1):75-85. PubMed ID: 19358813
[TBL] [Abstract][Full Text] [Related]
31. Neurons expressing individual enzymes of dopamine synthesis in the mediobasal hypothalamus of adult rats: functional significance and topographic interrelations.
Ugrumov M; Taxi J; Pronina T; Kurina A; Sorokin A; Sapronova A; Calas A
Neuroscience; 2014 Sep; 277():45-54. PubMed ID: 24997271
[TBL] [Abstract][Full Text] [Related]
32. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
33. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
34. Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-dopa?
Meister B; Hökfelt T; Steinbusch HW; Skagerberg G; Lindvall O; Geffard M; Joh TH; Cuello AC; Goldstein M
J Chem Neuroanat; 1988; 1(1):59-64. PubMed ID: 2908321
[TBL] [Abstract][Full Text] [Related]
35. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
36. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
[TBL] [Abstract][Full Text] [Related]
37. L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells.
Rodríguez-Martín E; Canals S; Casarejos MJ; de Bernardo S; Handler A; Mena MA
J Neurochem; 2001 Aug; 78(3):535-45. PubMed ID: 11483656
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of tyrosine hydroxylase by bulbocapnine.
Zhang YH; Shin JS; Lee SS; Kim SH; Lee MK
Planta Med; 1997 Aug; 63(4):362-3. PubMed ID: 9270381
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of tributyltin on dopamine biosynthesis in rat PC12 cells.
Kim YM; Lee JJ; Yin SY; Kim Y; Lee JK; Yoon YP; Kang MH; Lee MK
Neurosci Lett; 2002 Oct; 332(1):13-6. PubMed ID: 12377373
[TBL] [Abstract][Full Text] [Related]
40. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.
Allen GF; Ullah Y; Hargreaves IP; Land JM; Heales SJ
Neurochem Int; 2013 Apr; 62(5):684-94. PubMed ID: 23261515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
